 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 4 | 1/1 | 返回列表 |
| 查看: 1393 | 回復(fù): 3 | |||
zhangchong2303金蟲(chóng) (小有名氣)
|
[求助]
阿洛夫定（alovudine）新藥臨床幾期？
|
|
求助各位大俠，我想查詢一下阿洛夫定（alovudine）新藥臨床到幾期。一下我是美國(guó)的clinicaltrial上面查到的信息，看不懂是幾期怎么判斷。 Found 14 studies with search of: Alovudine Hide studies that are not seeking new volunteers. Hide studies with unknown recruitment status. Display Options Rank Status Study 1 Completed An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition: HIV Infections Intervention: Drug: Alovudine 2 Completed An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects Condition: HIV Infections Intervention: Drug: Alovudine 3 Completed A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) Condition: HIV Infections Intervention: Drug: Alovudine 4 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3'-Deoxy-3'-Fluorothymidine- Positron Emission Tomography (FLT-PET) Condition: Neuroblastoma Intervention: Device: FLT-PET 5 Recruiting Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) Conditions: High-grade Glioma; Astrocytoma; Glioblastoma Intervention: Radiation: 18F Fluorothymidine PET CT 6 Recruiting Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors Condition: Breast Cancer Interventions: Drug: BMS-754807; Drug: letrozole 7 Recruiting A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Conditions: Cancer; Solid Tumor; Lymphoma Intervention: Biological: 18F-FLT 8 Recruiting Image-Guided Stereotactic Biopsy of High Grade Gliomas Conditions: Brain Cancer; Glioma Intervention: Procedure: 18F-FLT PET Scan 9 Completed 18F-FLT-PET in Breast Cancer (MK-0000-139 AM1) Condition: Breast Cancer Intervention: Procedure: 18F-FLT-Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging 10 Recruiting Pilot Study of 18F-FLT PET Conditions: CNS Brain Metastasis; Head and Neck Cancer; Lung Cancer; Prostate Cancer; Esophageal Cancer Intervention: Procedure: Imaging with 18F-FLT PET 11 Terminated A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors Condition: Tumors of the Central Nervous System Intervention: Other: [18F]-Fluorothymidine 12 Recruiting An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine Condition: Pancreatic Cancer Intervention: Procedure: Positron-Emission Tomography (PET) 18F-FLT 13 Recruiting Validation of 18F-MISO-PET and 18F-FLT-PET Condition: Head and Neck Neoplasms Intervention: Procedure: 18F-FLT and 18F-MISO-PET 14 Recruiting Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors Condition: Lung Cancer Intervention: 求解釋?zhuān)浅８兄x |
回復(fù)此樓» 收錄本帖的淘帖專(zhuān)輯推薦
 新藥發(fā)現(xiàn) |
» 猜你喜歡
高效肺靶向RNA轉(zhuǎn)染，加速肺部RNA藥物開(kāi)發(fā)
已經(jīng)有2人回復(fù)
-
二糖的糖脂，合成后sephadex LH-20分離不出來(lái)，求助
已經(jīng)有1人回復(fù)
-
藥物學(xué)論文潤(rùn)色/翻譯怎么收費(fèi)?
已經(jīng)有252人回復(fù)
-
南方醫(yī)科大學(xué)珠江醫(yī)院肖計(jì)生課題組招收博士生 （2026年入學(xué)）
已經(jīng)有2人回復(fù)
-
349藥學(xué)專(zhuān)碩105500求調(diào)劑
已經(jīng)有0人回復(fù)
-
求調(diào)劑
已經(jīng)有1人回復(fù)
-
298求調(diào)劑一志愿中海洋
已經(jīng)有3人回復(fù)
-
292藥學(xué)調(diào)劑
已經(jīng)有1人回復(fù)
-
藥學(xué)調(diào)劑申請(qǐng)自薦信，一志愿中南大學(xué)
已經(jīng)有1人回復(fù)
-
藥學(xué)349專(zhuān)碩求調(diào)劑
已經(jīng)有1人回復(fù)
-
《左乙拉西坦注射液制備工藝研究、質(zhì)量控制和穩(wěn)定性研究》下載
已經(jīng)有1人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- Nat Biotech：2003-2011年新藥臨床研究成功率分析報(bào)告
已經(jīng)有6人回復(fù)
- 國(guó)外新藥，已經(jīng)進(jìn)入Ⅱ期臨床研究的新藥進(jìn)展情況如何查詢？？？
已經(jīng)有6人回復(fù)
- 中藥新藥臨床前研究藥學(xué)研究資料要注意什么才能提高通過(guò)率
已經(jīng)有3人回復(fù)
- 申報(bào)中藥新藥臨床批件到省局時(shí)的現(xiàn)場(chǎng)考核要注意什么？
已經(jīng)有4人回復(fù)
- 申請(qǐng)新藥臨床，已發(fā)批件，是否就是被批準(zhǔn)臨床？
已經(jīng)有10人回復(fù)
- 三期臨床，真的很難
已經(jīng)有17人回復(fù)
- 【求助】請(qǐng)問(wèn)新藥臨床試驗(yàn)的申報(bào)資料在哪里可以查到��？
已經(jīng)有7人回復(fù)
- 【求助】中藥新藥臨床研究指導(dǎo)原則第二輯 1993版
已經(jīng)有12人回復(fù)
- 【求助】新藥臨床前研究包括那些內(nèi)容
已經(jīng)有6人回復(fù)
nkbeholder
木蟲(chóng) (正式寫(xiě)手)
- DRDEPI: 1
- 應(yīng)助: 11 (小學(xué)生)
- 金幣: 2945.1
- 散金: 4
- 紅花: 5
- 帖子: 748
- 在線: 303.7小時(shí)
- 蟲(chóng)號(hào): 202353
- 注冊(cè): 2006-03-01
- 性別: GG
- 專(zhuān)業(yè): 藥物化學(xué)
【答案】應(yīng)助回帖
★
感謝參與，應(yīng)助指數(shù) +1
lk590(金幣+1): 謝謝參與 2012-02-02 11:31:54
zhangchong2303(金幣+10): ★★★很有幫助 謝謝，從這上面看應(yīng)該是臨床2期，是嗎？ 2012-02-02 13:47:37
感謝參與，應(yīng)助指數(shù) +1
lk590(金幣+1): 謝謝參與 2012-02-02 11:31:54
zhangchong2303(金幣+10): ★★★很有幫助 謝謝，從這上面看應(yīng)該是臨床2期，是嗎？ 2012-02-02 13:47:37
|
dialog上的信息，更新到2007年 Originator Company: Medivir AB (Sweden) Parent Company: Medivir AB Licensee: Beijing Mefuvir Medicinal Technology Highest Phase: Discontinued II Development Status: Discontinued II, France, HIV infections treatment Discontinued II, Sweden, HIV infections treatment Discontinued II, USA, HIV infections treatment |
2樓2012-02-02 11:28:31
nkbeholder
木蟲(chóng) (正式寫(xiě)手)
- DRDEPI: 1
- 應(yīng)助: 11 (小學(xué)生)
- 金幣: 2945.1
- 散金: 4
- 紅花: 5
- 帖子: 748
- 在線: 303.7小時(shí)
- 蟲(chóng)號(hào): 202353
- 注冊(cè): 2006-03-01
- 性別: GG
- 專(zhuān)業(yè): 藥物化學(xué)
3樓2012-02-02 13:49:56
iamzane
至尊木蟲(chóng) (著名寫(xiě)手)
- 應(yīng)助: 129 (高中生)
- 貴賓: 0.7
- 金幣: 24628.1
- 散金: 40
- 紅花: 21
- 帖子: 1974
- 在線: 459.5小時(shí)
- 蟲(chóng)號(hào): 330866
- 注冊(cè): 2007-03-24
- 專(zhuān)業(yè): 藥物學(xué)其他科學(xué)問(wèn)題
4樓2012-02-02 13:53:25
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 zhangchong2303 的主題更新
| 4 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
10
